Page last updated: 2024-08-23

pravastatin and Flushing

pravastatin has been researched along with Flushing in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blazing, MA; Duvall, WL; Guyton, JR; Saxena, S	1
Connelly, PW; Davignon, J; Gagné, C; Hayden, MR; Hegele, R; Lupien, PJ; McPherson, R; Montigny, M; Roederer, G; Tan, MH	1

Trials

1 trial(s) available for pravastatin and Flushing

Article	Year
Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia. The American journal of cardiology, 1994, Feb-15, Volume: 73, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Drug Combinations; Female; Flushing; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nausea; Niacin; Placebos; Pravastatin; Single-Blind Method; Triglycerides	1994

Article

Year

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.

The American journal of cardiology, 1994, Feb-15, Volume: 73, Issue:5

Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Drug Combinations; Female; Flushing; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nausea; Niacin; Placebos; Pravastatin; Single-Blind Method; Triglycerides

1994

Other Studies

1 other study(ies) available for pravastatin and Flushing

Article	Year
Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy. Journal of cardiovascular risk, 2002, Volume: 9, Issue:6 Topics: Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Disease; Drug Therapy, Combination; Female; Flushing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pravastatin; Retrospective Studies; Risk Factors; Treatment Outcome	2002

Article

Year

Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.

Journal of cardiovascular risk, 2002, Volume: 9, Issue:6

Topics: Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Coronary Disease; Drug Therapy, Combination; Female; Flushing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pravastatin; Retrospective Studies; Risk Factors; Treatment Outcome

2002